Drug intelligence / Profile preview

Qu Feng Zhi Tong

Development stage
Unknown
Lead developer
The First Affiliated Hospital of Harbin Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Qu Feng Zhi Tong is a Traditional Chinese Medicine (TCM) hospital preparation developed by the First Affiliated Hospital of Harbin Medical University, specifically indicated for the treatment of knee osteoarthritis (KOA). Formulated to address the TCM syndrome of wind-cold-dampness (Bi syndrome), the preparation typically consists of a blend of herbal extracts including *Radix Angelicae Pubescentis*, *Radix Gentianae Macrophyllae*, and *Cortex Eucommiae*. Pharmacologically, Qu Feng Zhi Tong exerts anti-inflammatory and analgesic effects by inhibiting the production of pro-inflammatory cytokines such as Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor (TNF). Additionally, it has been shown to modulate matrix metalloproteinases (MMPs), thereby reducing the degradation of articular cartilage and improving joint function in patients with degenerative joint diseases.

Other names
Qu Feng Zhi Tong Capsule祛风止痛胶囊Qu Feng Zhi Tong Jiao NangQu Feng Zhi Tong Liquid祛风止痛液
02

Targets

JUN (Transcription factor Jun)IL-6 (Interleukin 6)VEGFA (Vascular endothelial growth factor A)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Qu Feng Zhi Tong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qu Feng Zhi Tong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call